Comparison of Patterns of Coronary Artery Disease in Patients With Heart Failure by Cardiac Amyloidosis Status

Solomon S Beyene1, Omar Yacob2, Gebremedhin D Melaku1

  • 1MedStar Washington Hospital Center-Cardiology Department, USA.

Insights

Cardiac amyloidosis patients with heart failure are older but show fewer calcified and ostial coronary lesions. This study reveals distinct coronary artery patterns in heart failure with cardiac amyloidosis.

Area of Science:

  • Cardiology
  • Cardiovascular Diseases
  • Medical Imaging

Background:

  • Cardiac amyloidosis is a progressive disease that affects the heart.
  • Heart failure is a common complication of cardiac amyloidosis.
  • Coronary artery lesions can impact heart function and patient outcomes.

Purpose of the Study:

  • To characterize the pattern and severity of coronary artery lesions in patients with cardiac amyloidosis.
  • To compare coronary angiographic findings between heart failure patients with (HF/CA+) and without (HF/CA-) cardiac amyloidosis.

Main Methods:

  • Retrospective comparison of 110 heart failure patients (55 HF/CA+, 55 HF/CA-).
  • Demographic and angiographic data were analyzed for qualitative and quantitative variables.
  • Focus on major epicardial coronary vessels to determine patterns of involvement.

Main Results:

  • HF/CA+ patients were older (74.5 vs 54.1 years) but had significantly less severe calcification (0.0% vs 4.5%) and fewer ostial lesions (3.4% vs 15.1%).
  • HF/CA+ group showed a trend towards higher Thrombolysis in Myocardial Infarction (TIMI) frame count (30.4 vs 26.6), indicating reduced coronary blood flow.
  • Men in the HF/CA+ group had more tandem lesions compared to women (14.5% vs 0.0%).

Conclusions:

  • Heart failure patients with cardiac amyloidosis exhibit unique coronary lesion characteristics: older age, less calcification, reduced ostial involvement, and diminished coronary blood flow.
  • This is the first study to specifically examine coronary lesions in the context of heart failure with cardiac amyloidosis.
  • Findings suggest that cardiac amyloidosis influences coronary artery pathology differently than typical atherosclerosis.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
118
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
183
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
231
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
347
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
270